Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ambu A/S Unsponsored ADR (AMBBY : OTC)

• Company Description    Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark. Number of Employees: 5,196

• Price / Volume Information    Yesterday's Closing Price: $12.56 Daily Weekly Monthly 20 Day Moving Average: 268 shares Shares Outstanding: 234.97 (millions) Market Capitalization: $2,951.28 (millions) Beta: 0.85 52 Week High: $20.24 52 Week Low: $12.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -25.15% -27.11% 12 Week -12.57% -16.19% Year To Date -3.53% -15.68%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BALTORPBAKKEN 13 - BALLERUP,G7 DK-2750 DNK ph: 45-7225-2910 fax: - anhj@ambu.com http://www.ambu.com

• General Corporate Information    Officers Britt Meelby Jensen - Chief Executive Officer Jorgen Jensen - Chairman Steven Block - President Graziela Malucelli - Chief Operations Officer Henrik Bender - Chief Financial Officer Peer Information Ambu A/S Unsponsored ADR (MGLHQ) Ambu A/S Unsponsored ADR (AMBBY) Ambu A/S Unsponsored ADR (HMA.) Ambu A/S Unsponsored ADR (CPMIQ) Ambu A/S Unsponsored ADR (FPAMQ) Ambu A/S Unsponsored ADR (PSYS2) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-HOSPITALS Sector: Medical CUSIP: 02337W109 SIC: 6770 Fiscal Year Fiscal Year End: September Last Reported Quarter: 09/01/25 Next Expected EPS Date: 01/29/26 Share - Related Items Shares Outstanding: 234.97 Most Recent Split Date: (:1) Beta: 0.85 Market Capitalization: $2,951.28 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.23% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.03 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.08 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.04 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 01/29/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 36.94 PEG Ratio: - Price Ratios Price/Book: 3.29 Price/Cash Flow: 21.80 Price / Sales: 3.30 EPS Growth vs. Year Ago Period: 187.50% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 12.37% vs. Previous Quarter: 0.19% ROE 09/30/25 - 10.47 06/30/25 - 6.11 03/31/25 - 6.31 ROA 09/30/25 - 8.31 06/30/25 - 4.83 03/31/25 - 4.97 Current Ratio 09/30/25 - - 06/30/25 - 2.90 03/31/25 - 2.88 Quick Ratio 09/30/25 - - 06/30/25 - 1.73 03/31/25 - 1.67 Operating Margin 09/30/25 - 10.00 06/30/25 - 5.93 03/31/25 - 6.21 Net Margin 09/30/25 - 10.00 06/30/25 - 5.93 03/31/25 - 6.21 Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Book Value 09/30/25 - - 06/30/25 - 3.82 03/31/25 - 3.55 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - 0.08 03/31/25 - 0.08 Debt-to-Capital 09/30/25 - - 06/30/25 - 7.21 03/31/25 - 7.48

Powered by Zacks Investment Research ©